Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells by Furlanetto, Tania Weber et al.
259
Braz J Med Biol Res 34(2) 2001
Estradiol decreases iodide uptake by thyroid cellsBrazilian Journal of Medical and Biological Research (2001) 34: 259-263
ISSN 0100-879X
Estradiol decreases iodide uptake
by rat thyroid follicular FRTL-5 cells
1Divisão de Medicina Interna, Hospital de Clínicas de Porto Alegre,
Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
2Divisão de Endocrinologia, Departamento de Medicina,
Universidade Federal de São Paulo, São Paulo, SP, Brasil
T.W. Furlanetto1,
R.B. Nunes Jr.1,
A.M.I. Sopelsa1
and R.M.B. Maciel2
Abstract
Estradiol has well-known indirect effects on the thyroid. A direct
effect of estradiol on thyroid follicular cells, increasing cell growth
and reducing the expression of the sodium-iodide symporter gene, has
been recently reported. The aim of the present investigation was to
study the effect of estradiol on iodide uptake by thyroid follicular cells,
using FRTL-5 cells as a model. Estradiol decreased basal iodide
uptake by FRTL-5 cells from control levels of 2.490 – 0.370 to 2.085
– 0.364 pmol I-/µg DNA at 1 ng/ml (P<0.02), to 1.970 – 0.302 pmol
I-/µg DNA at 10 ng/ml (P<0.003), and to 2.038 – 0.389 pmol I-/µg
DNA at 100 ng/ml (P<0.02). In addition, 4 ng/ml estradiol decreased
iodide uptake induced by 0.02 mIU/ml thyrotropin  from 8.678 – 0.408
to 7.312 – 0.506 pmol I-/µg DNA (P<0.02). A decrease in iodide
uptake by thyroid cells caused by estradiol has not been described
previously and may have a role in goiter pathogenesis.
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Introduction
Estradiol has a well-known indirect ef-
fect on thyroid function, increasing thy-
roxine-binding globulin, probably due to
decreased clearance rather than increased
production of thyroxine-binding globulin
(1). This effect may be responsible for the
variations in thyroid size during the men-
strual cycle, as measured by ultrasonogra-
phy (2).
A direct effect of estradiol increasing
thyroid follicular cell growth and reducing
the expression of the sodium-iodide sym-
porter was recently described by one of us
(3) but the net result of these actions on
iodide uptake by thyroid cells is not known.
The objective of the present investigation
was to study the effect of estradiol on iodide
uptake by thyroid follicular cells under basal
conditions and after stimulation with thy-
rotropin (TSH), using FRTL-5 cells as a
model (4).
Material and Methods
Cell culture
FRTL-5 cells (American Type Culture
Collection, Rockville, MD, USA) were main-
tained in Hams F12 Coons modified medi-
um supplemented with 5% calf serum (Gibco
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BRL-Life Technologies, Gaithersburg, MD,
USA), 5 µg/ml transferrin, 10 µg/ml insulin,
1 mIU/ml TSH, 1 µg/ml amphotericin B
(Bristol-Myers Squibb, Santo Amaro, SP,
Brazil) and 20 µg/ml amikacin (Bristol-Myers
Squibb), in a humidified incubator at 37oC/
5% CO2, with a change of medium every 3 to
4 days. All media contained phenol red.
Iodide uptake
FRTL-5 cells (5 x 105 per well) were
plated onto 24-well plates. After 4 days,
cells were washed twice with warm PBS and
incubated in Hams F12 Coons modified
medium supplemented with 5% calf serum,
5 µg/ml transferrin, 10 µg/ml insulin, 1 µg/
ml amphotericin B, and 20 µg/ml amikacin
(2H medium). After starvation for 7 days
(-TSH), cells were treated as follows, in 2
different experiments:
Estradiol effect on basal iodide uptake.
Control group (2H medium), group treated
with 1 ng/ml estradiol (2H + 1 ng/ml estra-
diol), group treated with 10 ng/ml estradiol
(2H + 10 ng/ml estradiol), and group treated
with 100 ng/ml estradiol (2H + 100 ng/ml
estradiol). Twelve wells were used per treat-
ment group. Iodide uptake was determined
after 24 h.
Estradiol effect on iodide uptake stimu-
lated with TSH. Control group (2H medi-
um), TSH group (2H medium + 0.02 mIU/ml
TSH), and TSH + estradiol group (2H + 0.02
mIU/ml TSH + 4 ng/ml estradiol). Six wells
were used per treatment group. The treat-
ment medium was changed once and iodide
uptake was determined after 48 h.
Ethanol, used as solvent for estradiol,
was added as necessary so all treatment me-
dia had a 0.1% final content.
Iodide uptake was measured 48 h after
incubation with TSH and 24 h after incuba-
tion with estradiol, as described previously
(5). Briefly, cells were washed twice with
Hanks balanced salt solution-HEPES (HBSS-
H), pH 7.4, and incubated for 30 min at 37oC
with 0.5 ml of warm HBSS-H-0.4% albu-
min-10 µM sodium iodide-125I (NEN Dupont
Nez-033, Boston, MA, USA), approximately
0.1 µCi. After 30 min, well content was
quickly aspirated, cells were washed twice
with ice-cold PBS and 1 ml of 99% ethanol
was added to each well. Plates were kept for
1-2 h at room temperature and the content of
the wells was transferred to tubes. Radioac-
tivity was counted for 5 min (Autogama-
Cobra, Packard, Downers Grove, IL, USA)
in 3 tubes containing 0.5 ml of 99% ethanol
and 0.5 ml of 125I solution. Iodide uptake is
reported as picomole iodide per µg DNA per
well (pmol I-/µg DNA), with the total count
representing 5,000 pM of iodide. Iodide up-
take was calculated using the formula: (counts
observed/total count) x 5,000 pmol I-/µg
DNA.
DNA was measured by the diphenylamine
method (6). After ethanol removal, cells were
washed twice with cold PBS, and cold 5%
TCA was added for a period of 15 min to
several days at 4oC. TCA was aspirated and
a developing solution [20 ml A solution
(500 mg diphenylamine + 45 ml glacial ace-
tic acid + 1 ml 18 M H2SO4) + 8 ml ddH2O +
280 µl 1% acetaldehyde] was added for 24 h.
The results were read at 580 nm with a
spectrophotometer (IncibrÆs, Sªo Paulo, SP,
Brazil) and calculated according to the stan-
dards.
All experiments were repeated at least
twice and gave essentially the same results.
The data shown are those of a representative
experiment.
All reagents, unless stated, were obtained
from Sigma Chemical Co., St. Louis, MO,
USA.
Statistical analysis
Nonparametric one-way analysis of vari-
ance (Kruskal-Wallis test) was used for com-
parison between multiple groups and the
Mann-Whitney test was used to compare
two groups. All P values were two-sided and
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a P value of less than 0.05 was considered to
indicate statistical significance.
Results
Effect of estradiol on iodide uptake in the
absence of TSH
As shown in Figure 1, estradiol decreased
iodide uptake at all concentrations tested
compared to control (from 2.490 – 0.370  to
2.085 – 0.364 pmol I-/µg DNA at 1 ng/ml
(P<0.02), to 1.970 – 0.302 pmol I-/µg DNA
at 10 ng/ml  (P<0.003), and to 2.038 – 0.389
pmol I-/µg DNA at 100 ng/ml (P<0.02)).
Effect of estradiol in combination with TSH
on iodide uptake
As shown in Figure 2, 0.02 mIU/ml TSH
increased iodide uptake from 1.492 – 0.148
to 8.678 – 0.408 pmol I-/µg DNA (P<0.006),
and the addition of 4 ng/ml estradiol reduced
the effect of TSH to 7.312 – 0.506 pmol I-/
µg DNA (P<0.02).
Discussion
In the present study we examined the
effect of estradiol on iodide uptake by FRTL-
5 cells. A direct effect of estradiol on thyroid
follicular cells was expected because estro-
gen receptors are present in abundant
amounts in these cells (7-9).
We were able to demonstrate a decrease
in iodide uptake by estradiol-treated FRTL-5
cells in the presence and absence of TSH.
This effect was expected on the basis of the
estradiol-induced decrease in sodium-iodide
symporter gene expression observed previ-
ously in the presence of TSH, but not when
estradiol alone was used (3). Nevertheless,
estradiol alone was able to block iodide up-
take. This apparent discrepancy may have
been due to a better sensitivity of the iodide
uptake technique in measuring the effect of
estradiol under these conditions when com-
pared to the semi-quantitative method used
to measure the very low sodium-iodide sym-
porter gene expression in the absence of
TSH.
This report is the first to demonstrate a
decrease in iodide uptake by FRTL-5 in-
duced by estradiol. The observed effect was
quite mild and could have been influenced
by the presence of estrogenic activity in the
medium (steroid activity of phenol red pre-
sent in the medium, or inhibitory steroids in
serum). In addition, the concentrations of
estradiol used were supra-physiological and
experiments to study estrogen associated with
an antagonist of its action were not per-
formed, so that some nonspecific effect can-
not be excluded. Nevertheless, since the de-
crease of the sodium-iodide symporter gene
expression, described previously using simi-
lar experimental conditions, was fully re-
versed by ICI182780 (3), an estrogen an-
tagonist, we would expect the same to occur
for iodide uptake.
The mechanisms mediating the function
Figure 1 - Estradiol decreases
basal iodide uptake in FRTL-5
cells. Cells (5 x 105 per well)
were grown for 4 days in 24-
well plates, deprived of TSH for
7 days, and treated for 24 h with
no estradiol, 1 ng/ml estradiol,
10 ng/ml estradiol or 100 ng/ml
estradiol (12 wells per group).
Results are reported as mean ±
SD. Significance levels are
shown at the top of bars (Mann-
Whitney test). TSH, Thyrotropin.
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Figure 2 - Estradiol decreases
TSH-stimulated iodide uptake in
FRTL-5 cells. Cells (5 x 105 per
well) were grown for 4 days in
24-well plates, deprived of TSH
for 7 days, and treated for 48 h
with no TSH, 0.02 mIU/ml TSH
or 0.02 mIU/ml TSH associated
with 4 ng/ml estradiol, with one
change (6 wells per group). Re-
sults are reported as mean ±
SD. Significance levels are
shown at the top of bars (Mann-
Whitney test).
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of thyroid follicular cells are complex (10,11),
and how estradiol affects iodide uptake by
FRTL-5 cells is not understood. Estrogen
may have a direct nuclear effect on sodium-
iodide symporter gene expression, associ-
ated or not with a decrease in the ability of
the sodium-iodide symporter to carry iodide.
Another possible explanation is the produc-
tion of some estradiol-induced growth factor
able to decrease iodide uptake. Some growth
factors have shown this ability, like activin
A (12), epidermal growth factor (13,14),
TGF-a (15) and basic fibroblast growth fac-
tor (16). Thyroid follicular cells have been
shown to synthesize growth factors like IGFII
(17), TGF-ß (18,19) and endothelin-1 (20),
and have been observed in human thyroid
(21), so that estrogen-induced growth factor
production could potentially help to explain
the effect of estradiol.
No study has been conducted thus far to
verify if the estradiol-induced iodide uptake
by follicular cells is accompanied by a de-
crease in cell iodide content. It is well known
that the decrease in iodide content of thyroid
cells makes these cells more susceptible to
the effects of TSH (22,23). If there is a
decrease in the iodide content of thyroid
follicular cells induced by estradiol, this may
help to explain the increased prevalence of
goiter in women (24-26), even when their
TSH levels do not differ from those ob-
served in men. More studies should be done
to better understand the functional interrela-
tion of estradiol and thyroid follicular cells.
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